Related references
Note: Only part of the references are listed.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
Arnold S. Bayer et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia
O. Gasch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
Carol L. Moore et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
Pamela A. Moise et al.
LANCET INFECTIOUS DISEASES (2009)
High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
M. Sharma et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
